General Information of the Compound
Compound ID
CP0669680
Compound Name
(S)-4-Amino-N-[1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7Hpyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide
    Show/Hide
Synonyms
(S)-4-AMINO-N-(1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE
1143532-39-1
4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide
4-Amino-N-[(1s)-1-(4-Chlorophenyl)-3-Hydroxypropyl]-1-(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)piperidine-4-Carboxamide
4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1
AZD 5363
AZD-5363
AZD5363
C21H25ClN6O2
Capivasertib
UNII-WFR23M21IE
WFR23M21IE
capivasertib
cc-638
    Show/Hide
Structure
Formula
C21H25ClN6O2
Molecular Weight
428.924
Canonical SMILES
NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2nc[nH]c3nccc2-3)CC1
    Show/Hide
InChI
InChI=1S/C21H25ClN6O2/c22-15-3-1-14(2-4-15)17(6-12-29)27-20(30)21(23)7-10-28(11-8-21)19-16-5-9-24-18(16)25-13-26-19/h1-5,9,13,17,29H,6-8,10-12,23H2,(H,27,30)(H,24,25,26)/t17-/m0/s1
    Show/Hide
InChIKey
JDUBGYFRJFOXQC-KRWDZBQOSA-N
CAS
1143532-39-1
Physicochemical Property
logP
2.1005
Rotatable Bonds
6
Heavy Atom Count
30
Polar Areas
120.16
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
6
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25227436
SID: 57578635
ChEMBL ID
CHEMBL2325741
DrugBank ID
DB12218
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( Capivasertib )
Drug Name Capivasertib
Company AstraZeneca
Indication
Breast cancer
Approved
Triple negative breast cancer
Phase 3
Solid tumour/cancer
Phase 2
Target(s)
RAC-gamma serine/threonine-protein kinase (AKT3)
Modulator
RAC-alpha serine/threonine-protein kinase (AKT1)
Inhibitor